Table:
begin	end	state
1	20	cytoplasmic
21	38	transmembrane
39	53	non-cytoplasmic
54	75	transmembrane
76	89	cytoplasmic
90	110	transmembrane
111	115	non-cytoplasmic
116	137	transmembrane
138	148	cytoplasmic
149	174	transmembrane
175	183	non-cytoplasmic
184	204	transmembrane
205	251	cytoplasmic
252	273	transmembrane
274	292	non-cytoplasmic
293	311	transmembrane
312	317	cytoplasmic
318	337	transmembrane
338	341	non-cytoplasmic
342	361	transmembrane
362	371	cytoplasmic
372	395	transmembrane
396	404	non-cytoplasmic
405	426	transmembrane
427	447	cytoplasmic

Input:
>HSERO_RS05805
VNPSQSSTPAGLALTSAVSKIKWRILPLFVAMFIINYIDRVNIGFVRSHLSTDLGIGAAA
FGLGAGLFFVGYALFEVPSNMLLQRYGARAWLTRIMFTWGLVAACMAFVQSETSFYFMRF
LLGVAEAGFFPGVVYYFTQWLPNHERGRAMAVFLSGSAIASILSGPITGALLLIEGGGLH
GWQWMFIIEGGASMVFCVVVWLVLDSTPREAKWLSQEQREALAAVIAAEQEQRAANRPAH
VSALSLLRDPQIVLFCFIYFAIQLTIYGATFWLPTIIKKMGHFNDFQVGLFNSIPWIVAI
AAMYLFAVLAARYKKPQFWVATTLVISAAGMAISAVAGPVIGFVAVCFAGIGFKAASSLF
WPIPQAYLDARIAAAVLALINSLGNLGGFFAPATFGYLEQKTGSIQGGLFALSGASLLAA
VLVFLARTRPAAPDGGGPAEAAVKHAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server